CompletedNCT00406393
Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402)
PHASE3 · 304 planned enrolment
- Countries listed
- 2
- Registry update
- January 4, 2023
immortal.lifeTrial registrations containing the exact intervention label methotrexate.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE3 · 304 planned enrolment
PHASE3 · 300 planned enrolment
PHASE3 · 150 planned enrolment